Anti-cancer drug design:
Gespeichert in:
Späterer Titel: | Oncology research |
---|---|
Format: | Elektronisch Zeitschrift |
Sprache: | English |
Veröffentlicht: |
Elmsford, NY
Cognizant Communication Corporation
1996-2001
Oxford Oxford Univ. Press 1996-2001 |
Schlagworte: | |
Online-Zugang: | Volltext Volltext |
Veröffentlicht: | Nachgewiesen 11.1996 - 16.2001 |
Beschreibung: | Gesehen am 21.06.16 |
Beschreibung: | Online-Ressource |
ISSN: | 1460-2148 0266-9536 1555-3906 |
Internformat
MARC
LEADER | 00000nms a2200000 c 4500 | ||
---|---|---|---|
001 | BV012683624 | ||
003 | DE-604 | ||
005 | 20240416210741 | ||
006 | m|||| o||u| |||||| | ||
007 | cr|uuu---uuuuu | ||
008 | 991122d19962001xxk|| p|s|||| 0 ||eng d | ||
016 | 7 | |a 019763700 |2 DE-101 | |
016 | 7 | |a 1483489-3 |2 DE-600 | |
022 | |a 1460-2148 |2 6 | ||
035 | |a (OCoLC)1368075351 | ||
035 | |a (DE-599)ZDB1483489-3 | ||
040 | |a DE-604 |b ger | ||
041 | 0 | |a eng | |
044 | |a xxk |c XA-GB | ||
049 | |a DE-12 | ||
084 | |a 610 |2 22sdnb | ||
245 | 1 | 0 | |a Anti-cancer drug design |
264 | 3 | 1 | |a Elmsford, NY |b Cognizant Communication Corporation |c 1996-2001 |
264 | 3 | 1 | |a Oxford |b Oxford Univ. Press |c 1996-2001 |
300 | |a Online-Ressource | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
362 | 0 | |a Nachgewiesen 11.1996 - 16.2001 | |
363 | 0 | 0 | |8 1.1\x |a 11 |i 1996 |
363 | 1 | 0 | |8 1.2\x |a 16 |i 2001 |
500 | |a Gesehen am 21.06.16 | ||
650 | 0 | 7 | |a Cytostatikum |0 (DE-588)4068347-3 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Zeitschrift |0 (DE-588)4067488-5 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Aufsatzsammlung |0 (DE-588)4143413-4 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Online-Ressource |0 (DE-588)4511937-5 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Tumorhemmstoff |0 (DE-588)4292869-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Pharmakologie |0 (DE-588)4045687-0 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Arzneimitteldesign |0 (DE-588)4278218-1 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)4067488-5 |a Zeitschrift |2 gnd-content | |
689 | 0 | 0 | |a Tumorhemmstoff |0 (DE-588)4292869-2 |D s |
689 | 0 | 1 | |a Arzneimitteldesign |0 (DE-588)4278218-1 |D s |
689 | 0 | 2 | |a Zeitschrift |0 (DE-588)4067488-5 |D s |
689 | 0 | 3 | |a Online-Ressource |0 (DE-588)4511937-5 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Cytostatikum |0 (DE-588)4068347-3 |D s |
689 | 1 | 1 | |a Arzneimitteldesign |0 (DE-588)4278218-1 |D s |
689 | 1 | 2 | |a Zeitschrift |0 (DE-588)4067488-5 |D s |
689 | 1 | 3 | |a Online-Ressource |0 (DE-588)4511937-5 |D s |
689 | 1 | |5 ZDB | |
689 | 2 | 0 | |a Tumorhemmstoff |0 (DE-588)4292869-2 |D s |
689 | 2 | 1 | |a Pharmakologie |0 (DE-588)4045687-0 |D s |
689 | 2 | 2 | |a Zeitschrift |0 (DE-588)4067488-5 |D s |
689 | 2 | 3 | |a Online-Ressource |0 (DE-588)4511937-5 |D s |
689 | 2 | |5 ZDB | |
689 | 3 | 0 | |a Cytostatikum |0 (DE-588)4068347-3 |D s |
689 | 3 | 1 | |a Pharmakologie |0 (DE-588)4045687-0 |D s |
689 | 3 | 2 | |a Aufsatzsammlung |0 (DE-588)4143413-4 |D s |
689 | 3 | 3 | |a Online-Ressource |0 (DE-588)4511937-5 |D s |
689 | 3 | |5 ZDB | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |t Anti-cancer drug design |d Oxford : Oxford Univ. Press, 1985-2001 |x 0266-9536 |w (DE-604)BV002707042 |
785 | 0 | 0 | |i Aufgeg. in |t Oncology research |d New York, NY : Cognizant Communication Corporation, 1999- |h Online-Ressource |x 1555-3906 |w (DE-604)BV013661942 |
856 | 4 | 0 | |u http://www.ingentaconnect.com/content/cog/antcan |x Verlag; 12.1997 - 16.2001 |3 Volltext |
856 | 4 | 0 | |u https://ezb.ur.de/?1483489-3 |x EZB |3 Volltext |
943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-008620726 |
Datensatz im Suchindex
_version_ | 1814396780401393664 |
---|---|
adam_text | |
any_adam_object | |
building | Verbundindex |
bvnumber | BV012683624 |
ctrlnum | 1483489-3 (OCoLC)1368075351 (DE-599)ZDB1483489-3 |
dateSpan | Nachgewiesen 11.1996 - 16.2001 |
format | Electronic Journal |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nms a2200000 c 4500</leader><controlfield tag="001">BV012683624</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20240416210741</controlfield><controlfield tag="006">m|||| o||u| ||||||</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">991122d19962001xxk|| p|s|||| 0 ||eng d</controlfield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">019763700</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1483489-3</subfield><subfield code="2">DE-600</subfield></datafield><datafield tag="022" ind1=" " ind2=" "><subfield code="a">1460-2148</subfield><subfield code="2">6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1368075351</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)ZDB1483489-3</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxk</subfield><subfield code="c">XA-GB</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">22sdnb</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Anti-cancer drug design</subfield></datafield><datafield tag="264" ind1="3" ind2="1"><subfield code="a">Elmsford, NY</subfield><subfield code="b">Cognizant Communication Corporation</subfield><subfield code="c">1996-2001</subfield></datafield><datafield tag="264" ind1="3" ind2="1"><subfield code="a">Oxford</subfield><subfield code="b">Oxford Univ. Press</subfield><subfield code="c">1996-2001</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="362" ind1="0" ind2=" "><subfield code="a">Nachgewiesen 11.1996 - 16.2001</subfield></datafield><datafield tag="363" ind1="0" ind2="0"><subfield code="8">1.1\x</subfield><subfield code="a">11</subfield><subfield code="i">1996</subfield></datafield><datafield tag="363" ind1="1" ind2="0"><subfield code="8">1.2\x</subfield><subfield code="a">16</subfield><subfield code="i">2001</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Gesehen am 21.06.16</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Zeitschrift</subfield><subfield code="0">(DE-588)4067488-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Aufsatzsammlung</subfield><subfield code="0">(DE-588)4143413-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Online-Ressource</subfield><subfield code="0">(DE-588)4511937-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Tumorhemmstoff</subfield><subfield code="0">(DE-588)4292869-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimitteldesign</subfield><subfield code="0">(DE-588)4278218-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4067488-5</subfield><subfield code="a">Zeitschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Tumorhemmstoff</subfield><subfield code="0">(DE-588)4292869-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimitteldesign</subfield><subfield code="0">(DE-588)4278218-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Zeitschrift</subfield><subfield code="0">(DE-588)4067488-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Online-Ressource</subfield><subfield code="0">(DE-588)4511937-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Arzneimitteldesign</subfield><subfield code="0">(DE-588)4278218-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Zeitschrift</subfield><subfield code="0">(DE-588)4067488-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="3"><subfield code="a">Online-Ressource</subfield><subfield code="0">(DE-588)4511937-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">ZDB</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Tumorhemmstoff</subfield><subfield code="0">(DE-588)4292869-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="2"><subfield code="a">Zeitschrift</subfield><subfield code="0">(DE-588)4067488-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="3"><subfield code="a">Online-Ressource</subfield><subfield code="0">(DE-588)4511937-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">ZDB</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="1"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="2"><subfield code="a">Aufsatzsammlung</subfield><subfield code="0">(DE-588)4143413-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="3"><subfield code="a">Online-Ressource</subfield><subfield code="0">(DE-588)4511937-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="5">ZDB</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="t">Anti-cancer drug design</subfield><subfield code="d">Oxford : Oxford Univ. Press, 1985-2001</subfield><subfield code="x">0266-9536</subfield><subfield code="w">(DE-604)BV002707042</subfield></datafield><datafield tag="785" ind1="0" ind2="0"><subfield code="i">Aufgeg. in</subfield><subfield code="t">Oncology research</subfield><subfield code="d">New York, NY : Cognizant Communication Corporation, 1999-</subfield><subfield code="h">Online-Ressource</subfield><subfield code="x">1555-3906</subfield><subfield code="w">(DE-604)BV013661942</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.ingentaconnect.com/content/cog/antcan</subfield><subfield code="x">Verlag; 12.1997 - 16.2001</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://ezb.ur.de/?1483489-3</subfield><subfield code="x">EZB</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-008620726</subfield></datafield></record></collection> |
genre | (DE-588)4067488-5 Zeitschrift gnd-content |
genre_facet | Zeitschrift |
id | DE-604.BV012683624 |
illustrated | Not Illustrated |
indexdate | 2024-10-31T03:00:08Z |
institution | BVB |
issn | 1460-2148 0266-9536 1555-3906 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-008620726 |
oclc_num | 1368075351 |
open_access_boolean | |
owner | DE-12 |
owner_facet | DE-12 |
physical | Online-Ressource |
publishDate | 1996 |
publishDateSearch | 1996 1997 1998 1999 2000 2001 |
publishDateSort | 2001 |
publisher | Cognizant Communication Corporation Oxford Univ. Press |
record_format | marc |
spelling | Anti-cancer drug design Elmsford, NY Cognizant Communication Corporation 1996-2001 Oxford Oxford Univ. Press 1996-2001 Online-Ressource txt rdacontent c rdamedia cr rdacarrier Nachgewiesen 11.1996 - 16.2001 1.1\x 11 1996 1.2\x 16 2001 Gesehen am 21.06.16 Cytostatikum (DE-588)4068347-3 gnd rswk-swf Zeitschrift (DE-588)4067488-5 gnd rswk-swf Aufsatzsammlung (DE-588)4143413-4 gnd rswk-swf Online-Ressource (DE-588)4511937-5 gnd rswk-swf Tumorhemmstoff (DE-588)4292869-2 gnd rswk-swf Pharmakologie (DE-588)4045687-0 gnd rswk-swf Arzneimitteldesign (DE-588)4278218-1 gnd rswk-swf (DE-588)4067488-5 Zeitschrift gnd-content Tumorhemmstoff (DE-588)4292869-2 s Arzneimitteldesign (DE-588)4278218-1 s Zeitschrift (DE-588)4067488-5 s Online-Ressource (DE-588)4511937-5 s DE-604 Cytostatikum (DE-588)4068347-3 s ZDB Pharmakologie (DE-588)4045687-0 s Aufsatzsammlung (DE-588)4143413-4 s Erscheint auch als Druck-Ausgabe Anti-cancer drug design Oxford : Oxford Univ. Press, 1985-2001 0266-9536 (DE-604)BV002707042 Aufgeg. in Oncology research New York, NY : Cognizant Communication Corporation, 1999- Online-Ressource 1555-3906 (DE-604)BV013661942 http://www.ingentaconnect.com/content/cog/antcan Verlag; 12.1997 - 16.2001 Volltext https://ezb.ur.de/?1483489-3 EZB Volltext |
spellingShingle | Anti-cancer drug design Cytostatikum (DE-588)4068347-3 gnd Zeitschrift (DE-588)4067488-5 gnd Aufsatzsammlung (DE-588)4143413-4 gnd Online-Ressource (DE-588)4511937-5 gnd Tumorhemmstoff (DE-588)4292869-2 gnd Pharmakologie (DE-588)4045687-0 gnd Arzneimitteldesign (DE-588)4278218-1 gnd |
subject_GND | (DE-588)4068347-3 (DE-588)4067488-5 (DE-588)4143413-4 (DE-588)4511937-5 (DE-588)4292869-2 (DE-588)4045687-0 (DE-588)4278218-1 |
title | Anti-cancer drug design |
title_auth | Anti-cancer drug design |
title_exact_search | Anti-cancer drug design |
title_full | Anti-cancer drug design |
title_fullStr | Anti-cancer drug design |
title_full_unstemmed | Anti-cancer drug design |
title_new | Oncology research |
title_short | Anti-cancer drug design |
title_sort | anti cancer drug design |
topic | Cytostatikum (DE-588)4068347-3 gnd Zeitschrift (DE-588)4067488-5 gnd Aufsatzsammlung (DE-588)4143413-4 gnd Online-Ressource (DE-588)4511937-5 gnd Tumorhemmstoff (DE-588)4292869-2 gnd Pharmakologie (DE-588)4045687-0 gnd Arzneimitteldesign (DE-588)4278218-1 gnd |
topic_facet | Cytostatikum Zeitschrift Aufsatzsammlung Online-Ressource Tumorhemmstoff Pharmakologie Arzneimitteldesign |
url | http://www.ingentaconnect.com/content/cog/antcan https://ezb.ur.de/?1483489-3 |
zdb_num | 1483489-3 (DE-599)ZDB1483489-3 |